+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amryt Pharma plc - logo
HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

HIV-associated Lipodystrophy Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 190 Pages
  • Global
From
Somatostatin Analogs Market by Type, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Somatostatin Analogs Market by Type, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 195 Pages
  • Global
From
Severe Hypertriglyceridemia (SHTG) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Severe Hypertriglyceridemia (SHTG) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 142 Pages
  • Global
From
Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 136 Pages
  • Global
From
Somatostatin Analogs Global Market Report 2024 - Product Thumbnail Image

Somatostatin Analogs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Lomitapide Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lomitapide Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Radiodermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Radiodermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 54 Pages
  • Global
From
Familial Chylomicronemia Syndrome (FCS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Familial Chylomicronemia Syndrome (FCS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

  • Report
  • May 2024
  • 132 Pages
  • Global
From
Epidermolysis Bullosa Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Epidermolysis Bullosa Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 182 Pages
  • Global
From
Acromegaly Treatment Market by Disease Type, Drug Class, Distribution Channel, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Acromegaly Treatment Market by Disease Type, Drug Class, Distribution Channel, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 187 Pages
  • Global
From
Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2024 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Review, H2 2020 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 170 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 471 Pages
  • Global
From
Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • August 2022
  • 168 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 188 Pages
  • Global
From
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 78 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia (HoFH) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia (HoFH) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 259 Pages
  • Global
From
Atherosclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Atherosclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator